Published in Pharma Investments, Ventures and Law Weekly, January 13th, 2008
The landing page will include the offer of a white paper, and 90octane will deliver registrant information and tracking statistics to Symetix.
Keywords: 90octane, Pharmaceuticals.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.